According to Business Insider, "Several companies make DNA tests that claim to tell you how well you'll respond to certain antidepressants based on your genetic profile." Albertsons pharmacies in Chicago, Philadelphia, and Boise are offering the Genomind test through a pilot program. Daniel Dowd, Genomind's vice president of medical affairs, stated, "I think patients do tend to think, 'OK, this is going say exactly what this specific drug is going to do for me,' and that's not what this test is.